Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Recognize warning signs your budget is bad and learn practical tweaks to restore balance and reliability.
19,039 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
As the auto industry pivots toward electric and software-enabled services, the path for Ford stock over the next deca...
This deep dive breaks down AKA Brands' 2025 Q4 results. Learn what the numbers mean for the business, where growth ca...
Oracle has a booming backlog that signals future revenue, but it also requires massive spending. This article breaks ...
Oil has moved markets again, with crude flirting with triple digits and energy stocks lighting up in response. This g...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...
As AI reshapes every industry, a few standout names sit beneath the radar. This guide flags the best stocks wall stre...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...
Is AppLovin undervalued stock buy? This article breaks down the business, growth outlook, and valuation framework to ...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
Corporate treasuries are redefining crypto investing. This deep dive looks at how Strategy amassed a sizable Bitcoin ...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...